Volume 5 Supplement F

Foreword
Vascular Restoration Therapy: the fourth revolution in interventional cardiology and the ultimate “Rosy” prophecy
Wykrzykowska J, Onuma Y, Serruys PW
EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F7-F8
Part I – Bioabsorbable polymers in medicine
Bioabsorbable polymers in medicine: an overview
Vert M
EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F9-F14
Design principles and performance of bioresorbable polymeric vascular scaffolds
Oberhausern J, Hossainy S, Rapoza R
EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F15-F22
ABC’s of bioabsorption: application of lactide based polymers in fully resorbable cardiovascular stents
van Alst M, Eenink M, Kruft M, van Tuil R
EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F23-F27
The bioabsorption process: tissue and cellular mechanisms and outcomes
Vorpahl M, Finn A, Nakano M, Virmani R
EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F28-F35
Part II – Debates
Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent
Waksman R, Pakala R
EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F36-F42
Late loss in a disappearing frame of reference: is it still applicable to fully absorbable scaffolds?
Bangalore S, Mauri L
EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F43-F48
Vascular restoration therapy: what should the clinical and angiographic measures for success be?
Khattab A, Windecker S
EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F49-F53
Part III – Ploughing new ground, update of the bioabsorbable programmes
Engineering a bioresorbable stent: REVA programme update
Pollman M
EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F54-F57
Novel fully bioabsorbable salicylate-based sirolimuseluting stent
Jabara R, Pendyala L, Geva S, Chen J, Chronos N, Robinson K
EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F58-F64
OrbusNeich fully absorbable coronary stent platform incorporating dual partitioned coatings
Cottone R, Thatcher L, Parker S, Hanks L, Kujawa D, Rowland S, Costa M, Schwartz R, Onuma Y
EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F65-F71
Challenges related to development of bioabsorbable vascular stents
Berglund J, Guo Y, Wilcox J
EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F72-F79
Elixir Medical’s bioresorbable drug eluting stent (BDES) programme: an overview
Yan J, Bhat V
EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F80-F82
A.R.T.: concept of a bioresorbable stent without drug elution
Lafont A, Durand E
EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F83-F87
NEVO™: a new generation of sirolimus-eluting coronary stent
Falotico R, Parker T, Grishaber R, Price S, Cohen S, Rogers C
EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F88-F93
Current state of the absorbable metallic (magnesium) stent
Waksman R
EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F94-F97
Everolimus-eluting bioabsorbable stent – Abbot Vascular programme
Onuma Y, Piazza N, Ormiston J, Serruys PW
EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F98-F102
Assimilating the current clinical data of fully bioabsorbable stents
Di Mario C, Borgia F
EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F103-F108
Ten-year follow-up of the IGAKI-TAMAI stent.
Onuma Y, Garg S, Okamura T, Ligthart J, van Geuns R, de Feyter P, Serruys PW, Tamai H
EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F109-F111
Volume 5 Supplement F has been released thanks to the support of the following partners:
  • Abbott Vascular Devices
  • ART
  • Biotronik AG
  • Cordis, a Johnson & Johnson company
  • Medtronic
  • Orbus Neich

Online ISSN 1969-6213 - Print ISSN 1774-024X